Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > New series of Innovative Hydroxyapatite Biomaterials Developed at Ceram

Abstract:
Ceram, the materials technology consultancy, is pleased to announce that it has developed a new range of Hydroxyapatite (HA) biomaterials. By substituting different elements into HA to change its basic chemical whilst retaining its valuable physical structure, Ceram has been able to produce a range of biomaterials, multi-elements-substituted Hydroxyapatites (mx-HA), with different biological properties to extend the medical applications that HA can be used for and other potential applications not explored yet.

New series of Innovative Hydroxyapatite Biomaterials Developed at Ceram

Stoke-on-Trent, UK | Posted on December 12th, 2011

Although Hydroxyapatite has been widely used in the medical sector, it has had limited applications because of its fixed chemistry. Ceram's innovative technology has allowed different species, such as zinc and sulphate, to be substituted in conjunction into the HA crystal. The possibilities for this technology are endless; from the development of coatings which are both antimicrobial and osteo-promotive to bone cements that can have both a heightened bioactivity and modified structural characteristics (be that toughness, solubility, porosity or surface charge).

Ceram has filed for IP and is currently looking for biologics, medical devices and dental manufacturers to work with to develop bespoke HA based materials for bespoke applications. Ceram would also welcome additional collaboration with research institutes and academia to explore the new series of HA-based materials to find new applications.

####

About Ceram
Ceram is a materials technology consultancy that focuses on innovation, sustainability and quality assurance of materials. Headquartered in Staffordshire, UK, and with approved laboratories around the world, Ceram helps clients to overcome materials challenges and develop new products, processes and technologies, thereby enhancing profitability. Ceram operates in a wide range of sectors: healthcare and medical devices; construction; refractories; aerospace & defence; automotive & transport; consumer & retail; energy & environment; materials manufacturing; minerals; and semiconductor & electronics.

For more information, please click here

Contacts:
Mandy Rymill
Marketing Communications Manager
Stoke-on-Trent, UK
Tel: +44 (0)1782 764326

Copyright © Ceram

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Chemistry

Deep insights from surface reactions: Researchers use Stampede supercomputer to study new chemical sensing methods, desalination and bacterial energy production December 2nd, 2016

Scientists shrink electron gun to matchbox size: Terahertz technology has the potential to enable new applications November 25th, 2016

Tip-assisted chemistry enables chemical reactions at femtoliter scale November 16th, 2016

Nanomedicine

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

From champagne bubbles, dance parties and disease to new nanomaterials: Understanding nucleation of protein filaments might help with Alzheimer's Disease and type 2 Diabetes November 24th, 2016

Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016

Announcements

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Shape matters when light meets atom: Mapping the interaction of a single atom with a single photon may inform design of quantum devices December 4th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Novel Electrode Structure Provides New Promise for Lithium-Sulfur Batteries December 3rd, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project